0001209191-14-039150.txt : 20140623
0001209191-14-039150.hdr.sgml : 20140623
20140604200024
ACCESSION NUMBER: 0001209191-14-039150
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140602
FILED AS OF DATE: 20140604
DATE AS OF CHANGE: 20140604
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC
CENTRAL INDEX KEY: 0001001233
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 680359556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: 5109706000
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD
STREET 2: POINT RICHMOND TECH CNTR.
CITY: RICHMOND
STATE: CA
ZIP: 94804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gregory Philip D
CENTRAL INDEX KEY: 0001343543
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30171
FILM NUMBER: 14892282
MAIL ADDRESS:
STREET 1: POINT RICHMOND TECH CENTER II
STREET 2: 501 CANAL BOULEVARD SUITE A100
CITY: RICHMOND
STATE: CA
ZIP: 94804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-06-02
0
0001001233
SANGAMO BIOSCIENCES INC
SGMO
0001343543
Gregory Philip D
C/O SANGAMO BIOSCIENCES INC.,
POINT RICHMOND TECH CNTR, 501 CANAL BLVD
RICHMOND
CA
94804
0
1
0
0
SVP of Research & CSO
Common Stock
2014-06-02
4
M
0
7000
6.82
A
116347
D
Common Stock
2014-06-02
4
M
0
3000
3.45
A
119347
D
Common Stock
2014-06-02
4
M
0
5000
5.35
A
124347
D
Common Stock
2014-06-02
4
S
0
15000
12.8482
D
109347
D
Employee Stock Option (Right to Buy)
6.82
2014-06-02
4
M
0
7000
0.00
D
2016-12-12
Common Stock
7000
30000
D
Employee Stock Option (Right to Buy)
3.45
2014-06-02
4
M
0
3000
0.00
D
2018-12-09
Common Stock
3000
52500
D
Employee Stock Option (Right to Buy)
5.35
2014-06-02
4
M
0
5000
0.00
D
2019-12-06
Common Stock
5000
80000
D
Includes 33,333 shares, 26,666 shares, and 35,000 shares subject to restricted stock units granted on December 8, 2011, December 6, 2012, and December 12, 2013 respectively, which will be issued as such units vest in accordance with their terms.
The sales reported in this Form 4 were effected pursuant to the Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.22, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
All shares underlying this option are vested and immediately exercisable.
/s/ Florence Tam, attorney-in-fact
2014-06-04